JP Morgan Maintains Overweight on DuPont de Nemours, Raises Price Target to $172
JP Morgan analyst Chigusa Katoku maintains DuPont de Nemours (NYSE:DD) with a Overweight and raises the price target from $171 to $172.
Read original at benzingaStocks · News reference
UBS Maintains Buy on DuPont de Nemours, Raises Price Target to $178
UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $175 to $178.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 8:44 PM
- Checked
- Aug 5, 2026, 8:44 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
RBC Capital Maintains Outperform on DuPont de Nemours, Lowers Price Target to $176
Read original at benzinga'California sues DuPont over alleged effort to avoid ‘forever chemicals’ liabilities'- Financial Times
https://www.ft.com/content/77f00cf3-f2e6-4dcb-bf0d-1631ca45dd9c?syn-25a6b1a6=1&_gl=1*1lkg4gt*_up*MQ..&gclid=4b5f5274ad6f1d1dc16438006235df49&gclsrc=3p.ds
Read original at benzingaGlycolic Acid Market Size to Skyrocket USD 818.89 Million by 2035, Growing at 8.06% CAGR | SNS Insider
The global glycolic acid market is projected to grow from USD 377.21 million in 2025 to USD 818.89 million by 2035, driven by increasing demand for skincare products, alpha-hydroxy acid ingredients in cosmetics, and advanced formulation technologies. The U.S. market is expected to reach USD 180.61 million and Europe USD 228.65 million by 2035, with Asia Pacific currently holding the largest market share at 39%.
Read original at globenewswire-inc